Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimers Disease in Amnestic Mild Cognitive Impairment

机译：脑脊髓液生物标志物在轻度认知障碍中诊断前驱性阿尔茨海默氏病

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background/AimsDisease-modifying therapy for Alzheimer's disease (AD) has led to a need for biomarkers to identify prodromal AD and very early stage of AD dementia. We aimed to identify the cutoff values of cerebrospinal fluid (CSF) biomarkers for detecting prodromal AD.

机译：背景/目的针对阿尔茨海默氏病（AD）的疾病改良疗法已导致需要生物标志物来鉴定前驱性AD和AD痴呆的早期。我们旨在确定脑脊液（CSF）生物标志物的临界值，以检测前驱性AD。

著录项

期刊名称 Dementia and Geriatric Cognitive Disorders EXTRA
作者
Jung Eun Park; Kyu Yeong Choi; Byeong C. Kim; Seong-Min Choi; Min-Kyung Song; Jang Jae Lee; Jahae Kim; Ho-Chun Song; Hoo-Won Kim; Jung-Min Ha; Eun Hyun Seo; Woo Keun Song; Sung-Gyoo Park; Jung Sup Lee; Kun Ho Lee;
展开▼
作者单位

展开▼
年(卷),期 2019(9),1
年度 2019
页码 100–113
总页数 14
原文格式 PDF
正文语种
中图分类老年病学;老年卫生;
关键词
入库时间 2022-08-17 12:16:33

相似文献

外文文献
中文文献
专利

1. Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer’s Disease in Amnestic Mild Cognitive Impairment [J] . Park J.E., Choi K.Y., Kim B.C., Dementia and Geriatric Cognitive Disorders Extra . 2019,第1期

机译：脑脊髓液生物标志物在轻度认知障碍中诊断前驱性阿尔茨海默氏病
2. Predicting and Tracking Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease: Structural Brain Biomarkers [J] . Marizzoni Moira, Ferrari Clarissa, Jovicich Jorge, Journal of Alzheimer's disease: JAD . 2019,第1期

机译：预测和跟踪患有前甲醛疾病的急性认知障碍患者的短期疾病进展：结构脑生物标志物
3. Two-Year Longitudinal Monitoring of Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease Using Topographical Biomarkers Derived from Functional Magnetic Resonance Imaging and Electroencephalographic Activity [J] . Jovicich Jorge, Babiloni Claudio, Ferrari Clarissa, Journal of Alzheimer's disease: JAD . 2019,第1期

机译：使用源自功能磁共振成像和脑电图活性的地形生物标志物，两年的纵向监测Amnestic Alzheimer疾病的血清患者患者
4. EEG-based biomarkers on working memory tasks for early diagnosis of Alzheimer's disease and mild cognitive impairment [C] . Godofredo Quispe Mamani, Francisco J. Fraga, Guilherme Tavares, 2017 IEEE Healthcare Innovations and Point of Care Technologies . 2017

机译：基于脑电图的工作记忆任务生物标志物，可早期诊断阿尔茨海默氏病和轻度认知障碍
5. Cerebrospinal fluid biomarkers for the differential diagnosis of normal pressure hydrocephalus and Alzheimer's disease [D] . Assuras, Stephanie 2010

机译：脑脊液生物标记物用于正常压力脑积水和阿尔茨海默氏病的鉴别诊断
6. Cerebrospinal Fluid Levels of Amyloid Beta 1–43 in Patients with Amnestic Mild Cognitive Impairment or Early Alzheimer’s Disease: A 2-Year Follow-Up Study [O] . Camilla Lauridsen, Sigrid B. Sando, Adiba Shabnam, 2016

机译：记忆力轻度认知障碍或早期阿尔茨海默氏病患者的脑脊髓液淀粉样蛋白1-43的水平：一项为期两年的随访研究
7. Two-Year Longitudinal Monitoring of Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer’s Disease Using Topographical Biomarkers Derived from Functional Magnetic Resonance Imaging and Electroencephalographic Activity [O] . Jorge Jovicich, Claudio Babiloni, Clarissa Ferrari, 2019

机译：使用源自功能磁共振成像和脑电平移活性的地形生物标志物，两年的纵向监测患有前甘露阿尔茨海默氏病的血清患者患者

Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimers Disease in Amnestic Mild Cognitive Impairment

摘要

著录项

相似文献

相关主题

期刊订阅